<DOC>
	<DOCNO>NCT00641524</DOCNO>
	<brief_summary>The purpose study evaluate use phlebotomy ( blood take ) treatment patient non-alcoholic fatty liver disease .</brief_summary>
	<brief_title>Evaluation Phlebotomy Treatment Non-alcoholic Fatty Liver Disease</brief_title>
	<detailed_description>In study phlebotomy evaluate therapy non-alcoholic fatty liver disease ( NAFLD ) , common important cause liver disease . Phlebotomy use many year treatment disorder iron overload hemochromatosis , well tolerated improves symptom survival . There evidence also effective treat NAFLD . However , previous study evaluate whether phlebotomy improve liver biopsy finding . We measure severity disease NAFLD patient prior phlebotomy therapy end treatment . This allow u accurately determine benefit therapy patient .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Patients 18y old Diagnosis Nonalcoholic Fatty Liver Disease Unable unwilling provide inform consent Alcohol consumption &gt; 10g/day woman &gt; 20g/day men</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Non-alcoholic fatty liver disease</keyword>
	<keyword>liver fibrosis</keyword>
	<keyword>metabolic syndrome</keyword>
	<keyword>iron overload</keyword>
	<keyword>phlebotomy</keyword>
</DOC>